Foundation Medicine Inc (FMI)-Medical Equipment-Deals and Alliances Profile

Foundation Medicine Inc (FMI)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME254034D
  • |
  • Pages: 60
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas and others. It also offers additional materials, services, and real-time data through its technology products. The company partners with biotech and pharmaceutical companies to develop targeted cancer therapies and active clinical trials. Foundation Medicine is headquartered in Cambridge, Massachusetts, the US.

Foundation Medicine Inc (FMI)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Foundation Medicine Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Foundation Medicine Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Foundation Medicine Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Foundation Medicine Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Foundation Medicine Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Foundation Medicine Inc, Medical Equipment, Deal Details 12

Venture Financing 12

Cota Raises Funds through Venture Financing 12

Foundation Medicine Raises US$56 Million In Series B Financing 13

Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing 14

Foundation Medicine Raises US$10 Million In Venture Financing 16

Partnerships 16

Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 16

Foundation Medicine Enters into Agreement with AstraZeneca 17

Foundation Medicine Enters into Agreement with Mirati Therapeutics 18

IMS Health Enters into Agreement with Foundation Medicine 18

Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 19

Foundation Medicine Extends Co-Development Agreement With Clovis Oncology 20

Foundation Medicine Expands Co-Development Agreement With Novartis 21

Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 22

Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 23

Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 24

Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology 24

Foundation Medicine Extends Co-Development Agreement With Novartis 25

Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 26

Foundation Medicine Enters Into An Agreement With Novartis 27

Equity Offering 28

Foundation Medicine Raises USD250 Million in Private Placement of Shares 28

Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 29

Foundation Medicine Completes IPO Of Shares For US$122 Million 30

Foundation Medicine Inc-Key Competitors 32

Key Employees 33

Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Recent Developments 35

Strategy And Business Planning 35

Jun 08, 2017: ASCO and Foundation Medicine Announce Collaboration to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization Study 35

Financial Announcements 36

May 09, 2017: Foundation Medicine Announces 2017 First Quarter Results and Recent Highlights 36

Feb 22, 2017: Foundation Medicine Announces 2016 Fourth Quarter and Year-End Results, Recent Highlights and 2017 Outlook 38

Jan 09, 2017: Foundation Medicine Reports Preliminary 2016 Results 39

Nov 02, 2016: Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights 41

Aug 02, 2016: Foundation Medicine Announces 2016 Second Quarter Results and Recent Highlights 43

May 03, 2016: Foundation Medicine Announces 2016 First Quarter Results and Recent Highlights 45

Feb 23, 2016: Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook 46

Corporate Communications 47

Jan 06, 2017: Foundation Medicine Announces Executive Leadership Transition 47

Oct 27, 2016: Foundation Medicine Adds Life Sciences Leader Michael R. Dougherty to its Board of Directors 48

Product News 49

May 18, 2017: Foundation Medicine and Its Collaborators to Present New Data at ASCO 2017 Supporting the Integration of Comprehensive Genomic Profiling in Personalized Clinical Care in Oncology 49

Aug 22, 2016: Foundation Medicine Adds New Immunotherapy Features to Its Market-Leading Products 51

May 17, 2016: Foundation Medicine Receives Patent Covering Fundamental Methods in Comprehensive Genomic Analysis in Cancer 52

Mar 23, 2016: Foundation Medicine and Memorial Sloan Kettering Publish Validation Data for FoundationOne Heme in the Journal Blood 53

Mar 17, 2016: Foundation Medicine Announces Presentations at the AACR Annual Meeting 2016 55

Mar 16, 2016: Foundation Medicine Presents New Data at the 2016 USCAP Annual Meeting Underscoring Importance of Comprehensive Genomic Profiling in Cancer Care 57

Other Significant Developments 59

Feb 25, 2016: Foundation Medicine Announces First-Ever Public Release of Broad Pediatric Data From FoundationCORE to Accelerate the Development of Precision Medicine Strategies for Pediatric Cancers 59

Appendix 60

Methodology 60

About GlobalData 60

Contact Us 60

Disclaimer 60

List of Figures

Foundation Medicine Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Foundation Medicine Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Foundation Medicine Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Foundation Medicine Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Foundation Medicine Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Foundation Medicine Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Foundation Medicine Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Foundation Medicine Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Foundation Medicine Inc, Medical Equipment, Key Facts, 2016 1

Foundation Medicine Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Foundation Medicine Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Foundation Medicine Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Foundation Medicine Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Foundation Medicine Inc, Deals By Market, 2011 to YTD 2017 9

Foundation Medicine Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Cota Raises Funds through Venture Financing 12

Foundation Medicine Raises US$56 Million In Series B Financing 13

Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing 14

Foundation Medicine Raises US$10 Million In Venture Financing 16

Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 16

Foundation Medicine Enters into Agreement with AstraZeneca 17

Foundation Medicine Enters into Agreement with Mirati Therapeutics 18

IMS Health Enters into Agreement with Foundation Medicine 18

Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 19

Foundation Medicine Extends Co-Development Agreement With Clovis Oncology 20

Foundation Medicine Expands Co-Development Agreement With Novartis 21

Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 22

Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 23

Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 24

Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology 24

Foundation Medicine Extends Co-Development Agreement With Novartis 25

Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 26

Foundation Medicine Enters Into An Agreement With Novartis 27

Foundation Medicine Raises USD250 Million in Private Placement of Shares 28

Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 29

Foundation Medicine Completes IPO Of Shares For US$122 Million 30

Foundation Medicine Inc, Key Competitors 32

Foundation Medicine Inc, Key Employees 33

Foundation Medicine Inc, Other Locations 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Foundation Medicine Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16235
Site License
USD 500 INR 32470
Corporate User License
USD 750 INR 48705

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com